Knowledge

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:

Publications

Hogan Lovells Publications

Supreme Court tightens standing requirements for class actions Class Action and Appellate Client Alert

On Friday, the Supreme Court issued a decision holding that all class members must prove Article III standing to recover individual damages. The opinion will be useful authority for...

News

FDA expands mutual reliance and harmonization with foreign regulators for inspectional oversight

The U.S. Food and Drug Administration’s (FDA) commitment to expand mutual reliance with trusted regulatory partners may be a silver lining for biomedical innovation during an...

News

FDA issues guidance on conducting remote interactive evaluations during the COVID-19 pandemic

On April 14, the U.S. Food and Drug Administration (FDA) released the immediately-in-effect guidance “Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring...

News

Court puts health care providers on notice that illegal kickbacks can trigger significant damages

The United States Court of Appeals for the Fourth Circuit recently affirmed a $114 million judgment in a protracted, and hotly contested, suit filed under the qui tam provisions of the...

News

Safeguarding drug development at academic institutions

Academic institutions and faculty engaged in developing novel drug therapies are navigating an increasingly complex compliance landscape. Innovative therapies are moving from university...

News

FCA Podcast Series: 2020 and the road ahead

In addition to the False Claims Act Guide: 2020 and the road ahead, we are featuring a six-part podcast series based on select sections of the report. Go behind-the-scenes for more in-depth ...

Hogan Lovells Publications

Aerospace & Defense Insights | Roadmap for False Claims Act enforcement in 2021

The federal government's recoveries from investigations and cases involving the False Claims Act (FCA) fell in fiscal year (FY) 2020 to US$2.2 billion from US$3.05 billion in FY2019.

Media Mention

GP-led Secondaries Report 2021 Private Equity International

In a recent report produced by Private Equity International, Ed Harris and Adam Brown comment on the expanding GP-led secondaries market, including restructurings, continuation funds and...

News

The False Claims Act Guide: 2020 and the road ahead

The pace of False Claims Act (FCA) litigation remained furious over the past year. Companies and individuals in all sectors of the economy continue to face the threat of FCA investigation,...

Loading data